ASHPOfficial

Anticoagulants are moving to the frontline in some patients with COVID-19 as emerging data shows pro-thrombotic complications occurring. Many of these agents are weight based and require lab monitoring for efficacy and safety. Unfortunately, obesity is an ongoing epidemic in the US as well and potentially worse outcomes in those with COVID-19. It is imperative that pharmacists have an understanding on how the pharmacokinetics can be altered in patients that are obese or large body weight, along with the recommended dosing weight to use.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

While it is not uncommon to occasionally have adult-sized patients in children’s hospitals, some are preparing to support the care of more adult patients in the event of COVID-19 surge in their region. This means that pharmacists who traditionally only care pediatric patients will be caring for adult patients without conditions that are associated with pediatrics diseases. Our guests today are pediatric pharmacists from across the country who will share with us their experiences and plans to safely care for patients.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Due to the COVID-19 pandemic, our pharmacotherapy clinic had to rapidly create new workflows for telehealth services to allow for continued care of our patients, while minimizing their possible exposure to COVID-19.  We will be discussing how we have rapidly converted our face-to-face pharmacist visits to telehealth visits to minimize patient exposure in the ambulatory care clinics, as well as, pharmacist/provider exposure to patients unnecessarily. In addition, we will discuss the types of telehealth visits provided, the roadblocks we have encountered/lessons learned and current reimbursement for such services.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

CAR-T cell therapies have the potential to transform cancer treatment. Their unique toxicities require rapid recognition and specialized treatment. Collaboration between multiple disciplines is needed for the optimal management of patients undergoing CAR-T cell therapy. The purpose of this podcast is to discuss key issues that non-oncology practitioners in acute care settings will need to be familiar with to appropriately treat patients whom underwent CAR-T cell treatment and are experiencing adverse effects related to treatment.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Our ASHP members are in various stages of preparing for, responding to, and recovering from the COVID-19 global pandemic. This is an extremely difficult time and as we – pharmacists, pharmacy residents, students pharmacists, and pharmacy technicians - continue to care for our patients, it is even more imperative to step-up our well-being for ourselves and the healthcare workforce community. Today, we chat with Jennifer Phillips and Jennifer Locker about managing resilience and well-being of staff members during the COVID pandemic.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.